Prenatal Supplement With Dha has 8 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Carbamazepine, Fosphenytoin, Macrolide Antibiotics. Patients taking Prenatal Supplement With Dha should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 8
- Moderate
- 8
Moderate (8)
- Prenatal Supplement With Dha + Carbamazepine— High doses of folic acid may result in decreased serum levels of carbamazepine.
- Prenatal Supplement With Dha + Fosphenytoin— High doses of folic acid may result in decreased serum levels of fosphenytoin.
- Prenatal Supplement With Dha + Macrolide Antibiotics— Zinc can inhibit absorption of certain antibiotics; separate administration by at least 2 hours to minimize interaction.
- Prenatal Supplement With Dha + Methotrexate— Folic acid may decrease a patient's response to methotrexate.
- Prenatal Supplement With Dha + Phenobarbital— High doses of folic acid may result in decreased serum levels of phenobarbital.
- Prenatal Supplement With Dha + Phenytoin— High doses of folic acid may result in decreased serum levels of phenytoin.
- Prenatal Supplement With Dha + Thyroid— Anti-thyroid drugs used with iodine supplementation may lead to hypothyroidism.
- Prenatal Supplement With Dha + Valproic Acid— High doses of folic acid may result in decreased serum levels of valproic acid.